NFKB1 and cholangiocarcinoma: TWEAK can provoke NF-kB-driven chemotaxis-associated signaling during the steps of CCA progression demonstrating that the TWEAK/Fn14 pathway is increasingly expressed in multi-species (human–mouse) CCA [39].